The study showed that participants who took Bimagrumab lost a significant amount of body fat compared to those who took a placebo (a pill with no active ingredient)
For people who need to manage both weight and blood sugar, Semaglutide offers a dual benefit
Most clinical guidelines suggest that there is no direct contraindication for using semaglutide in patients with common, benign (non-cancerous) thyroid conditions like hypothyroidism or Hashimotos disease
With more treatment options available and accessible to patients, the more hope the medical community has for reversing the climbing overweight and obesity rates in the United States
Jensen MT, Nielsen SS, Jessen-Winge C, Madsen CMT, Thilsing T, Larrabee Snderlund A, et al
Join the countless individuals who have transformed their lives with the help of tirzepatide weight loss treatment and start your journey today